Wilson Bryan, M.D., Former Director of FDA CBER's Office of Tissues and Advanced Therapies, Joins Greenleaf
WASHINGTON--(BUSINESS WIRE)--Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces that Wilson Bryan, M.D., has joined as Executive Vice President, Drug and Biological Products. Wilson served as Director of the Office of Tissues and Advanced Ther...
Source: pharmiweb.com